Arthritis & Rheumatism

Tofacitinib ups rheumatoid arthritis treatment response

(HealthDay)—The addition of tofacitinib to rheumatoid arthritis (RA) treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Aug. ...

Medications

Improvement needed of prescription drug postmarketing studies

"Because rare but potentially serious adverse events of prescription drugs are often discovered only after market approval, observational postmarketing studies constitute an important part of the U.S. drug safety system," ...

page 7 from 7